Logo

Oxis in Talks to Establish Oxidative-Stress Biomarker Collaborations

Jan 17, 2005

NEW YORK, Jan. 17 (GenomeWeb News) - Oxis International said last week that it is in discussions with a number of researchers and university laboratories to research the role of oxidative-stress biomarkers in human and animal disease.


According to the company, the initial focus of the project will be on bovine spongiform encephalopathy; Creutzfeld-Jacob disease; type II diabetes; atherosclerosis; hepatitis; and neurodegenerative disorders such as Alzheimer's disease.

 

As such, Oxis said it is discussing partnerships with Claudio Soto, a researcher from the University of Texas Medical Branch; Jacek Rozga, president and CEO of Arbios Systems; Manifred Windisch, CEO of JSW Research; Noah Berkowitz, CEO of Haptoguard; and Jay Heinecke, a researcher from the University of Washington, Seattle.

 

Details about the discussions were not disclosed.

Breaking News
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.